Exploratory Phase 0/1 of Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Latest Information Update: 05 Nov 2021
At a glance
- Drugs ODS 2004436 (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Diagnostic use; First in man
- Acronyms IMKRUN 2
- 23 Jan 2020 Status changed from recruiting to completed.
- 08 Aug 2018 Planned End Date changed from 1 Sep 2018 to 27 Mar 2019.
- 05 Jun 2018 Results (n=8) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.